1. Home
  2. ORMP vs ASMB Comparison

ORMP vs ASMB Comparison

Compare ORMP & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

HOLD

Current Price

$2.99

Market Cap

104.6M

Sector

Health Care

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$32.63

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORMP
ASMB
Founded
2002
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.6M
553.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ORMP
ASMB
Price
$2.99
$32.63
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$43.40
AVG Volume (30 Days)
226.0K
108.4K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
838.25
N/A
EPS
1.03
N/A
Revenue
$2,000,000.00
$37,191,000.00
Revenue This Year
N/A
$42.01
Revenue Next Year
N/A
N/A
P/E Ratio
$2.90
N/A
Revenue Growth
N/A
31.30
52 Week Low
$1.82
$7.75
52 Week High
$3.20
$39.71

Technical Indicators

Market Signals
Indicator
ORMP
ASMB
Relative Strength Index (RSI) 66.16 39.54
Support Level $2.66 $35.05
Resistance Level $3.19 $36.92
Average True Range (ATR) 0.13 1.93
MACD 0.02 -0.63
Stochastic Oscillator 61.12 1.94

Price Performance

Historical Comparison
ORMP
ASMB

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: